Drug Profile
Ulinastatin
Alternative Names: Miraclid; MR-20VLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Mochida Pharmaceutical
- Class Anti-inflammatories; Cytoprotectives; Furans; Glycoproteins; Uroprotectives
- Mechanism of Action Enzyme inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Pancreatitis; Vascular disorders
- Suspended Preterm labour